Analysis of co-morbidities and treatment of TB at Ananta Institute.

| Posted in: Health Sciences Science

Journal name: World Journal of Pharmaceutical Research
Original article title: A retrospective analysis of the co-morbidities and treatment schedule of pulmonary tuberculosis reporting at ananta institute of medical sciences and research centre, rajsamand, rajasthan
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.

Original source:

This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.

Author:

Swapnil Panchal, Pushprajsinh Vaghela, Sherin Mary Rajan, Harshita Kalal and Komal Sharma


World Journal of Pharmaceutical Research:

(An ISO 9001:2015 Certified International Journal)

Full text available for: A retrospective analysis of the co-morbidities and treatment schedule of pulmonary tuberculosis reporting at ananta institute of medical sciences and research centre, rajsamand, rajasthan

Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research

Doi: 10.20959/wjpr20237-28069

Copyright (license): WJPR: All rights reserved


Download the PDF file of the original publication


Summary of article contents:

Introduction

Tuberculosis (TB), primarily caused by Mycobacterium tuberculosis, is a chronic infectious disease that predominantly manifests as pulmonary tuberculosis but can affect any organ. India has one of the highest incidences of TB globally, with a significant number of cases exacerbated by co-morbid conditions, notably HIV. The World Health Organization estimates millions of new TB cases annually, emphasizing the urgency for effective treatment and management strategies. The present study, conducted at the Ananta Institute of Medical Sciences and Research Centre in Rajasthan, aimed to analyze co-morbidities and treatment plans for patients diagnosed with pulmonary tuberculosis during a one-year period from March 2021 to February 2022.

Impact of Co-Morbidities on TB Outcomes

Co-morbidities significantly complicate TB management, particularly in patients with HIV, diabetes, and malnutrition. The study highlighted that 3.42% of patients with TB were diagnosed with diabetes while the same percentage also suffered from HIV. These conditions not only increase the likelihood of TB reactivation but also hamper the effectiveness of treatment, as patients with weakened immune systems are less able to combat the infection. This interplay leads to worse clinical outcomes, as co-infections create a vicious cycle of deteriorating health that can escalate the severity of TB and complicate its treatment.

Treatment Protocol and Challenges

The standard treatment for pulmonary tuberculosis involves an intensive two-month phase followed by a four-month continuation phase, utilizing a combination of first-line anti-TB drugs such as isoniazid, rifampicin, pyrazinamide, and ethambutol. In the observed cohort, treatment adherence was monitored via the Nikshay Portal, with most patients complying with the regimen. However, the presence of co-morbidities necessitated alterations in drug dosages for some patients, emphasizing the need for individualized treatment plans. Notably, the study found no cases of multidrug-resistant TB (MDR-TB), suggesting effective management practices, although the potential for underreporting of drug resistance remains a concern.

The Role of Monitoring Systems

The study underscores the critical role of monitoring systems, such as the Nikshay Portal, in managing TB treatment. This database allows healthcare providers to track patient progress, medication adherence, and associated health conditions. Such systems facilitate timely intervention when complications arise and enhance communication between patients and healthcare facilities. The tracking mechanism proved effective during the study, as the majority of patients accessed their monthly anti-TB medications effectively, with only a few defaults in treatment reported. This eye on patient adherence is vital to achieving the ultimate goal of reducing TB incidence.

Conclusion

The findings from the retrospective analysis at Ananta Institute of Medical Sciences highlight the significance of understanding co-morbid conditions in pulmonary tuberculosis management. Recognizing that co-morbidities like HIV and diabetes exacerbate treatment challenges underlines the importance of integrated healthcare approaches. Furthermore, effective monitoring systems such as the Nikshay Portal play a pivotal role in promoting treatment adherence and optimizing patient outcomes. Ongoing efforts must focus on adequately addressing these complexities to reduce the incidence of TB, particularly in high-prevalence areas like India.

FAQ section (important questions/answers):

What is the main cause of pulmonary tuberculosis?

Pulmonary tuberculosis is primarily caused by Mycobacterium tuberculosis, a chronic infectious bacterium that can affect various organs but predominantly impacts the lungs.

What are the common symptoms of pulmonary tuberculosis?

Common symptoms include fever, weight loss, cough, and anorexia. If untreated, it can lead to severe complications and even death.

What is the standard treatment regimen for TB?

The standard treatment consists of an intensive two-month phase with Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, followed by four months of Isoniazid and Rifampicin.

How does HIV affect tuberculosis infection rates?

HIV coinfection significantly raises the risk of developing active tuberculosis due to compromised immune function, making individuals more susceptible to both primary infection and reactivation.

What are the challenges in treating tuberculosis in India?

Challenges include treatment complexity, non-compliance due to side effects, and rising drug resistance significantly complicating effective management and eradication efforts.

What are the co-morbidities commonly associated with TB?

Common co-morbidities include diabetes, HIV infection, and malnutrition, all of which can exacerbate tuberculosis and complicate treatment.

Glossary definitions and references:

Scientific and Ayurvedic Glossary list for “Analysis of co-morbidities and treatment of TB at Ananta Institute.”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.

1) Tuberculosis:
Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis. It primarily affects the lungs, but can spread to other organs. TB is a major health concern in many developing countries, including India, where it poses a significant burden on public health and requires extensive treatment protocols.

2) Drug:
Drugs are chemical substances used for medical treatment. In tuberculosis management, the effectiveness of various drugs is crucial. The study evaluates co-morbidities, treatment regimens, and patient compliance with prescribed drug therapies to understand outcomes associated with TB treatment.

3) Disease:
Diseases designate pathological conditions affecting organisms. Tuberculosis is a prominent infectious disease, alongside other communicable and non-communicable diseases, impacting global health. Understanding disease interactions and comorbidities is essential for comprehensive treatment approaches.

4) Medicine:
The medicine pertains to the various anti-tubercular agents used to treat the infection. Understanding the specific roles, dosages, and side effects of TB medicines is crucial for improving treatment adherence and patient outcomes.

5) Study (Studying):
The study reports retrospective data from tuberculosis patients at Ananta Institute of Medical Sciences. It aims to investigate co-morbidities and treatment outcomes, contributing to the understanding of TB management and population health dynamics in the region.

6) Line:
In pharmacology and treatment guidelines, 'line' refers to the categorization of treatment options. First-line drugs are the initial preferred therapies used to treat tuberculosis, while second-line drugs are used when resistance to first-line options occurs, thus affecting treatment efficacy and patient outcomes.

7) India:
India is a country with one of the highest burdens of tuberculosis in the world. It has significant public health challenges related to TB, including a high incidence of multi-drug-resistant cases. Understanding the disease dynamics in India is vital for formulating effective control strategies.

8) Science (Scientific):
Sciences encompass various disciplines that study the physical and natural world, including medical science, biological science, and pharmacology. Each discipline plays a vital role in understanding tuberculosis's biology, epidemiology, and drug responses to improve patient care and disease management strategies.

9) Ananta (Anamta):
Ananta Institute of Medical Sciences is a healthcare facility that serves as the study's focal point. The institute provides essential tuberculosis diagnostic and treatment services, facilitating the collection of data concerning patient demographics, treatment protocols, and health outcomes in the region.

10) Developing:
Developing refers to countries or regions with lower levels of industrialization and lower income levels. In the context of tuberculosis, developing countries face significant challenges in disease management, healthcare infrastructure, and socio-economic factors that contribute to heightened TB incidence and prevalence.

11) Quality:
Quality in healthcare pertains to the standard of services provided to patients. In tuberculosis treatment, ensuring high-quality care includes accurate diagnosis, effective drug regimens, and comprehensive follow-up to enhance treatment outcomes and minimize the risk of drug resistance.

12) Malnutrition:
Malnutrition significantly affects immune system function, making individuals more susceptible to infections like tuberculosis. The study notes the association of malnutrition among TB patients, as addressing nutritional needs is critical for improving health outcomes and treatment efficacy.

13) Species:
In biological context, species refers to a group of organisms with common characteristics capable of interbreeding. Mycobacterium tuberculosis is a crucial species studied in the context of tuberculosis, understanding its pathogens' characteristics aids in finding effective treatments.

14) Activity:
Activity refers to the functional efficacy of a drug against a specific pathogen. In tuberculosis treatment, assessing the activity of anti-TB drugs like isoniazid and rifampicin is crucial for selecting effective treatment regimens and improving patient outcomes.

15) Pharmacology:
Pharmacology is the study of drugs and their effects on biological systems. It plays a vital role in understanding drug mechanisms, dosing regimens, and potential side effects, particularly for tuberculosis treatment and managing drug-resistant strains of the disease.

16) Antibiotic (Antibacterial):
Antibacterial refers to compounds that kill or inhibit bacterial growth. In the context of tuberculosis, effective antibacterial agents are critical for treating the infection, with the need to monitor drug resistance patterns to ensure continued efficacy of treatment protocols.

17) Rajasthan:
Rajasthan is a state in India and the location of the Ananta Institute of Medical Sciences. The region's health infrastructure and tuberculosis prevalence significantly impact the local population, underscoring the necessity for targeted TB control programs and access to quality healthcare.

18) Dividing:
Dividing refers to the process of cell division, specifically in the context of Mycobacterium tuberculosis, which notably divides slowly. Understanding the growth rate and reproduction of TB bacilli aids in determining the appropriate duration and type of treatment required for effective management.

19) Udaipur (Udaypur):
Udaipur is a city in Rajasthan, India, representing the area where Bhupal Nobles' College of Pharmacy is located. The college plays a significant role in educating future pharmacists and healthcare professionals focused on addressing public health issues like tuberculosis in the region.

20) Account:
In a medical research context, 'account' refers to documenting and analyzing patient data and outcomes. The study aims to account for the number of confirmed tuberculosis cases, co-morbidities, and treatments administered, providing insights for improving healthcare strategies and patient management.

21) Fever:
Fever is a common symptom associated with tuberculosis, often indicating infection. Accompanying other symptoms like cough and weight loss, fever plays a pivotal role in the symptomatology of the disease, contributing to the clinical assessment and diagnosis of TB.

22) Blood:
Blood is a vital fluid in the body that can sometimes be affected by diseases like tuberculosis. In TB cases, blood tests are relevant for identifying co-morbidities or tracking immune responses, playing a crucial role in diagnosing and managing the infection.

23) Wall:
Walls often refer to cellular structures, particularly in bacteria like Mycobacterium tuberculosis. The composition and integrity of bacterial cell walls are pivotal in understanding virulence and developing effective antibiotics against tuberculosis.

24) Pur:
Poor refers to low socioeconomic status, which is often associated with increased susceptibility to diseases like tuberculosis. Poor living conditions, lack of access to healthcare, and malnutrition contribute to higher TB incidence and complications in disadvantaged populations.

25) Discussion:
Discussion facilitates the interpretation and analysis of study findings. Engaging with data regarding tuberculosis cases and treatments enables healthcare professionals and policymakers to identify gaps, propose improvements, and formulate strategies for better disease management and prevention.

26) Toxicity:
Toxicity refers to the potential harmful effects of drugs on the body. In tuberculosis treatment, monitoring for toxicity of anti-TB medications is crucial, as adverse effects can lead to non-compliance and hinder successful treatment outcomes.

27) Family:
Family in this context may relate to the classification of organisms, such as Mycobacteriaceae. The understanding of the bacterial family can provide insights into treatment strategies and the relationships of different mycobacterial species affecting human health.

28) Marai:
Marai refers to a subset within the broader context of populations impacted by tuberculosis. The epidemiological factors in the Marai population may present unique challenges that necessitate tailored public health interventions to combat TB effectively.

29) Table:
Table typically refers to a structured presentation of data in research. In the study, various tables summarize patient demographics, treatment outcomes, and co-morbidities, enabling clear representation of findings and aiding in data interpretation.

30) Death:
Death, particularly from infectious diseases like tuberculosis, highlights the severity of untreated TB in populations. Understanding mortality rates and associated risk factors is critical for implementing effective public health measures aimed at reducing TB-related deaths.

31) Sign:
Sign refers to any indication or symptom of a disease. In tuberculosis, signs such as cough, weight loss, and fever help clinicians diagnose and monitor the course of the disease, ultimately informing treatment decisions.

32) Road:
Road reflects the broad journey of individual patients navigating their tuberculosis diagnosis and treatment. Understanding patient experiences along this path emphasizes the importance of holistic healthcare approaches and support systems throughout treatment.

33) Chemotherapy:
Chemotherapy refers to the treatment of disease using drugs. In the context of tuberculosis, chemotherapy specifically pertains to anti-TB medications aimed at eradicating the infection and preventing further transmission, emphasizing the need for an effective and well-tolerated treatment regimen.

34) Transmission:
Transmission describes the mechanism through which tuberculosis spreads from one individual to another, primarily through airborne droplets. Understanding transmission dynamics is crucial for controlling TB outbreaks and implementing effective public health interventions.

35) Swallowing:
Swallowing refers to the act of taking food or substances into the body. In tuberculosis, it may pertain to how patients ingest medications or the clinical relevance when TB invades organs like the digestive tract in extrapulmonary cases.

36) Epidemic:
Epidemic refers to a sudden increase in disease cases within a specific geographic area. Tuberculosis can present as an epidemic in many regions, necessitating enhanced public health responses and resources to manage and control disease spread effectively.

37) Vaghela:
Pushprajsinh Vaghela is one of the authors associated with the study on tuberculosis. The research contributions of authors are essential for understanding the collaborative nature of medical research, which informs clinical practices and health policies.

38) Leprosy:
Leprosy is an infectious disease caused by Mycobacterium leprae. Although distinct from tuberculosis, understanding the similarities between these mycobacterial infections, including treatment challenges, can provide valuable insights into managing chronic infectious diseases.

39) Surface:
Surface often refers to the outer layer of cells or organisms. In tuberculosis, the bacterial cell wall's surface properties play a crucial role in pathogenicity, influencing immune response and drug interactions.

40) Cancer:
Cancer represents a significant public health concern characterized by uncontrolled cell growth. The relationship between tuberculosis and cancer is noteworthy as co-morbidity may complicate TB management, necessitating a holistic approach in treating patients with both conditions.

41) Sharman (Sarma, Sarman, Sharma):
Komal Sharma is mentioned as a contributor to the study, highlighting the collaborative effort in researching tuberculosis. Understanding diverse perspectives contributes to comprehensive data analysis, ensuring all aspects of TB management are addressed.

42) Animal:
Animal studies play a vital role in medical research, providing insights into disease mechanisms, including tuberculosis. Research on animal models allows researchers to test treatments and understand disease interactions before human studies.

43) Labour (Labor):
Labour refers to the employment of physical or mental exertion in work. In the context of tuberculosis, occupational exposures and working conditions may affect infection rates and highlight the importance of public health measures in economic activities.

44) Indian:
Indian denotes nationality and context within which tuberculosis is studied. Public health challenges related to TB are particularly pronounced in India, necessitating culturally appropriate strategies for prevention and treatment efforts.

45) Rajan:
Sherin Mary Rajan is another contributor to the study, emphasizing the teamwork and diverse expertise necessary to tackle complex public health issues like tuberculosis, which requires ongoing research and collaboration among health professionals.

46) Rupee:
Rupee refers to the currency of India. Economic factors, including the cost of healthcare services and access to medication for tuberculosis treatment, influence patient compliance and health outcomes, highlighting the socio-economic aspects of disease management.

47) Sugar:
Sugar generally indicates glucose levels in the blood, relevant in assessing diabetes prevalence among tuberculosis patients. High sugar levels can compromise the immune response, increasing susceptibility to TB infection and affecting treatment outcomes.

48) Birth:
Birth signifies the beginning of life. In the context of tuberculosis, maternal health during pregnancy can impact neonatal outcomes. The relationship between TB, maternal health, and childhood diseases highlights the need for comprehensive research on reproductive health.

49) Fight:
Fight refers to the struggle against disease. In tuberculosis research, this often involves examining public health strategies, treatment approaches, and community education aimed at controlling and eradicating this infectious disease.

50) Cina:
China is a country where significant tuberculosis burden exists, similar to India. Comparing TB eradication strategies and public health policies between China and India can inform shared lessons learned in managing this global health issue.

51) Egypt:
Egypt may relate to historical studies on tuberculosis as well as modern public health challenges. Understanding the epidemiology of TB in different regions, including its historical spread, is essential for contemporary control efforts.

52) Food:
Food directly influences health and nutritional status, which is critical for tuberculosis patients. Proper nutrition supports immune function and recovery, highlighting the importance of dietary interventions in effective TB treatment programs.

53) Bird:
Bird is often used metaphorically to refer to surveillance or monitoring in public health contexts. In the study of tuberculosis, understanding how diseases spread within communities is key to developing monitoring and intervention strategies.

54) Viru:
Viru might not have a direct reference but could imply a connection to virulence in pathogens. Understanding the virulence factors of Mycobacterium tuberculosis is essential for developing targeted therapies and effective disease control strategies.

55) Life:
Life signifies the overall health and well-being of individuals. In the context of tuberculosis, improving life quality through effective treatment, early diagnosis, and patient education is essential for managing this chronic infectious disease effectively.

Other Science Concepts:

[back to top]

Discover the significance of concepts within the article: ‘Analysis of co-morbidities and treatment of TB at Ananta Institute.’. Further sources in the context of Science might help you critically compare this page with similair documents:

Treatment plan, Pulmonary tuberculosis, Treatment duration, Health care system, Drug resistance, Retrospective Analysis, World Journal of Pharmaceutical Research, Mycobacterium tuberculosis, Treatment compliance, Extra-pulmonary tuberculosis, HIV POSITIVE INDIVIDUALS, MDR-TB, XDR-TB, Directly Observed Treatment Short Course, Diagnosis of tuberculosis, Incidence of tuberculosis, Anti-tubercular medication, Directly Observed Treatment Short Course (DOTS), HIV co-infection, Sputum analysis, Miliary tuberculosis, Co-infection with HIV, Diabetes and tuberculosis.

Let's grow together!

I humbly request your help to keep doing what I do best: provide the world with unbiased sources, definitions and images. Your donation direclty influences the quality and quantity of knowledge, wisdom and spiritual insight the world is exposed to.

Let's make the world a better place together!

Like what you read? Help to become even better: